About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, November 9th, 2012

The QualityStocks
Daily Stock List


American Sands Energy Corp. (AMSE)

Today we are reporting on American Sands Energy Corp. (AMSE), here at the QualityStocks Daily Newsletter.

Headquartered in Salt Lake City, Utah, American Sands Energy Corp. is an oil sands exploration and development company operating in the state of Utah. The Company has acquired rights to oil sand ore covering approximately 2,000 acres of prime oil sand deposits in the Sunnyside area of Utah.  American Sands has an extraction and recovery system using a licensed proprietary solvent that separates oil and other hydrocarbons from sand, dirt and other substances without creating tailing ponds and other environmental hazards. American Sands Energy lists on the OTC Bulletin Board.

The Company has the rights to mine oil sand ore and extract bitumen from private property located near Price, Utah (the Sunnyside Lease).   The Sunnyside Lease area contains some of the prime oil sands deposits in Utah. American Sands has the rights to acreage with estimated net P50 resources of 200 million barrels of recoverable bitumen to the Company. The planned plant and mine site of the Sunnyside Lease is approximately seven miles from an existing power plant, rail head, and major state highway. The site is accessible by county road and will be served by existing power lines.

American Sands' process has proven successful in laboratory tests on oil sands from the Green River Formation in Utah. The validity of this technology has been demonstrated via the operation of a prototype extraction unit. At full production, the Company expects to produce 50,000 barrels of oil daily, employing conventional underground mining and an extraction and recovery system using a proprietary solvent. Their extraction system consumes no water in its process.

In October, American Sands Energy announced that they engaged Teneo Securities, LLC to act as the Company's financial advisor in a public offering. In a press release dated October 12, 2012, American Sands Energy CEO, Mr. William Gibbs, stated, "With our successful pilot tests concluded, American Sands is ready to move forward on our plans to construct a 5,000 barrel per day production facility. Teneo Securities' team of experienced energy bankers is well suited to assist the Company with our goal of funding development through an IPO on a major exchange."

American Sands Energy Corp. (AMSE), closed today at $1.06, up 100.00%, on 61,150 volume with 11 trades. The average volume for the last 60 days is 1,075 and the stock's 52-week low/high is $0.05/$1.40.

CAMAC Energy, Inc. (CAK)

Eagle Financial Publications and FeedBlitz reported recently on CAMAC Energy, Inc. (CAK), Trade of the Week, TradingAuthorityDaily, Forbes, and TopStockAnalysts did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

CAMAC Energy, Inc. is an energy company that engages in the exploration, development and production of oil and gas. They focus on early cash flow and high-return global energy projects. CAMAC has offices in Houston, Texas and Lagos, Nigeria. They recently acquired six exploration blocks in Kenya and Gambia. Founded in 2005, the Company is currently pursuing further additions to their exploration portfolio in East and West Africa.

CAMAC Petroleum Ltd. and their parent company CAMAC Energy have access to technical expertise, experience and established networks in the E&P business in the West Africa region through CAMAC Energy's largest shareholder CAMAC Energy Holdings Ltd., a subsidiary of CAMAC International Ltd.  Founded in 1986, CAMAC International is a privately owned international energy company. They are involved in the exploration, development and operation of oil properties in Africa and South America.

CAMAC Energy's principal assets include interests in OML 120 and OML 121, offshore oil leases in deepwater Nigeria that started production from the Oyo Field in December 2009.  The Oyo Oilfield is located approximately 75 miles off the Southern Nigerian coast in deep-water (200-500 meters). CAMAC Energy has an interest in a Production Sharing Contract (PSC) covering petroleum operations in the Oyo Oilfield under the Oil Mining Lease 120 issued by the Federal Republic of Nigeria. Under the PSC, CAMAC Energy has partnered with Nigerian Agip Exploration Ltd. (a subsidiary of Italy's ENI SpA); the Oyo Oilfield's other interest holder and operating contractor.

Today, CAMAC Energy provided an operational update and announced their third quarter 2012 results. During the third quarter, they announced that Allied Energy PLC, an affiliate of their largest shareholder and the operator of their deep water blocks, OML 120 and OML 121 achieved several critical milestones related to the drilling of Oyo well #7 currently scheduled to spud in the first quarter of 2013. In October, the Company announced that Allied had engaged Axxis Petroconsultants Limited as project manager for the drilling of Oyo well #7.

CAMAC Energy expects initial production from Oyo well #7 to triple the oil production volumes from current levels and that the additional production from the proposed Oyo well #8, will result in a 2013 gross exit production rate greater than 15,000 barrels of oil per day. This 2013 exit rate estimate does not include current gas production of 43 million cubic feet per day. CAMAC and Allied have commissioned an engineering study on a gas monetization solution that would yield natural gas liquid production and reduced greenhouse gas emissions.

Average daily gross production from the Oyo Field in Nigeria was 2,641 barrels of oil per day during the third quarter of 2012. This is in comparison to 3,514 barrels of oil per day during the third quarter of 2011. CAMAC Energy's share of average daily net production at the Oyo Field, excluding royalty, was 388 barrels of oil per day for the quarter ended September 30, 2012, and 833 barrels of oil per day for the quarter ended September 30, 2011.

CAMAC Energy, Inc.(CAK), closed Friday's trading at $0.44, up 15.79%, on 154,313 volume with 362 trades. The average volume for the last 60 days is 96,920 and the stock's 52-week low/high is $0.36/$1.20.

United American Petroleum Corp. (UAPC)

StreetAuthority Financial, Real Pennies, Weiss Research, Street Authority Trade of the Week, UltimatePennyStock, and Terry's Tips reported earlier on United American Petroleum Corp. (UAPC), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Trading on the OTC Bulletin Board, United American Petroleum Corp. is an independent exploration, development, acquisition, production, and operating company. They engage in advanced exploration, drilling and completion techniques to explore for, produce, and develop domestic oil and natural gas reserves. Their main current projects are in the state of Texas. Additional acquisitions may encompass active plays throughout the United States. United American Petroleum is based in Austin, Texas.

The Company has 11 main projects that are producing. Moreover, they own interests in several other projects. Their operating division performs outsourced oil and gas services to other oil and gas companies. United American has more than 4,000 acres in 10 counties with 178 wellbores. Their Texas projects include Gabriel Rosser, Lozano, Marcee, Welder, Walker Smith, and Bailey, Rogers & Fahn. They also include Mckinney, Crouch, Lane Heady, Merrick Davis, and Mckenzie.

United American Petroleum's objective is to achieve enterprise success through concentrating on near-term production and low-risk acquisitions. In addition, their corporate goal is to maintain and grow the operations side of the business to continue growth of company revenue. Relating to Operations, the Company is presently providing operational services for a number of oil and gas leaseholders in 15 counties state-wide, covering close to 8,000 acres, containing 250 existing wellbores with many offset drilling locations identified. They are exploring opportunities to increase the size and locations of their operations portfolio. 

Earlier this year, United American Petroleum announced that sustained production from their Marcee well located in Gonzales County, Texas was achieved.  In early September, they announced that they completed the scheduled workover and acid stimulations to their Lozano lease in Frio County, Texas. Previously, the Lozano lease produced approximately 5 bbls of oil daily from its three existing wellbores. Currently, production from the Lozano lease has increased and stabilized at a rate of approximately 15 bbls of oil per day from the three existing wellbores.

Last week, United American Petroleum announced that they appointed Mr. Albert Hough and Mr. John Whitehead as members of their Advisory Board. Mr. Hough and Mr. Whitehead are experienced well site drilling consultants who've supported operations of many Fortune 500 oil and gas companies.

United American Petroleum Corp. (UAPC), closed Friday's session at $0.19, up 11.11%, on 30,444 volume with 16 trades. The average volume for the last 60 days is 37,296 and the stock's 52-week low/high is $0.11/$1.50.

Smart-Tek Solutions, Inc. (STTN)

BullRally, CoolPennyStocks, HotOTC, Stock Rich, and Stockpalooza reported previously on Smart-Tek Solutions, Inc.(STTN), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Smart-Tek Solutions, Inc. by way of their subsidiary, Smart-Tek Automated Services, Inc., provides professional employer organization (PEO) outsourcing and human resources services to small and medium-size businesses in the United States. In addition, through their Solvis Medical business line the Company provides medical staffing services to hospitals, medical clinics, surgical centers, skilled nursing facilities, and nursing care to patients in their homes. Smart-Tek Solutions' shares trade on the OTC Markets: OTCQB. The Company has their corporate headquarters in Newport Beach, California.

Smart-Tek Solutions' services allow customers to outsource human resources tasks. These include payroll processing, workers' compensation insurance, employee benefits administration, risk management, and human resource administration, as well as services related to staff leasing, temporary staffing, and co-employment. The Company's solutions relieve their clients from many of the day-to-day tasks that negatively affect their core business operations.

The Company's plan of operation for the short term is to continue to concentrate on signing up new brokers who have a large book of business that they can service. In addition, their plan of operation for the short term is also to grow their new nurse staffing business line.

Smart-Tek Solutions' plan of operation for the long term is to expand their service business, including staff - and nurse staffing leasing, PEO services, and value added products and services to small and medium-size businesses. Being a human resource department and strategic business partner for their clients the Company's service offerings allow their clients to comply with ever evolving complex employment related regulatory and tax issues; increase productivity by improving employee satisfaction and retention; reduce payroll expenses with lower workers' compensation costs; and focus on core business activities instead of human resource matters.

With their primary business, a co-employment or PEO contract arrangement, Smart-Tek becomes a co-employer of the client's existing workforce and assumes some or all of the client's human resource management responsibilities.

Smart-Tek Solutions, Inc. (STTN), closed at $0.009, up 5.88%, on 34,500 volume with 5 trades. The average volume for the last 60 days is 49,603 and the stock's 52-week low/high is $0.007/$0.07.

Nevada Gold & Casinos, Inc. (UWN)

SmarTrend Newsletters, Top Secret Stocks, Sling-Shot-Stocks, ChartPoppers, Global Equity Report, 24-7 Stock Alert, Penny Stock Explosion, and Trading News Bulletin reported earlier on Nevada Gold & Casinos, Inc. (UWN), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

Nevada Gold & Casinos, Inc. was established in 1977, and since 1994, the Company has primarily been a gaming company involved in financing, developing, owning and operating gaming properties. Their gaming facility operations are in the U.S., specifically in the states of Washington and South Dakota. The Company's business strategy continues to focus on owning and operating gaming establishments. Nevada Gold & Casinos lists on the NYSE Market.

The Company  is a developer, owner and operator of 10 gaming operations in Washington (Washington Gold) and a 950-machine slot route operation in Deadwood, South Dakota (South Dakota Gold). In addition, Nevada Gold & Casinos has a gaming license in Nevada and an interest in Buena Vista Development Company, LLC, which is working on a Native American casino project to undergo development in Ione, California.

The Company is actively seeking collaborations in owning, developing and managing gaming facilities - domestically and around the world. Their team members have experience in gaming markets globally. In addition to owning and operating their properties, Nevada Gold & Casinos provides development, marketing and management expertise to selected properties. They provide strategic consulting services to help meet the objectives in developing, operating and positioning their business enterprise. The Company's management team brings an ownership philosophy to gaming facilities in casino management/operations for all kinds of gaming venues.

In mid-October, Nevada Gold & Casinos announced the implementation of a cost reduction program, and other organizational changes and initiatives.

Mr. Ernest East, the Company's interim President, stated, "We have conducted an in-depth review of the company's cost structure and have implemented a program to reduce costs by more than $750,000 annually. As part of that program, we will close our corporate office in Houston and move most of the functions located there to our regional office in Seattle. In addition, we will expand Nevada Gold's current office in Las Vegas and, beginning in the first quarter of 2013, that office will serve as our corporate headquarters. With Las Vegas as our new home, we will improve our access to acquisition opportunities and our participation in industry developments. Also, the move permits us to more fully leverage opportunities arising from our recent approval for a gaming license in the State of Nevada."

Nevada Gold & Casinos, Inc. (UWN), closed Friday's trading session at $0.74, down 2.63%, on 20,188 volume with 35 trades. The average volume for the last 60 days is 24,060 and the stock's 52-week low/high is $0.75/$1.81.

Red Rock Energy, Inc. (RRK.V)

We are highlighting Red Rock Energy, Inc. (RRK.V) today, here at the QualityStocks Daily Newsletter.

Headquartered in Calgary, Alberta, Red Rock Energy, Inc. engages in the acquisition, exploration, and development of properties for the production of uranium, and oil and gas in Canada. The Company is transitioning from uranium exploration and development into light oil development in the Western Canadian Sedimentary Basin. Trading on the TSX-Venture Exchange since 2007, Red Rock Energy was founded in 2005.

Concerning Oil & Gas, Red Rock Energy has a light oil play focused on low risk bypassed pay in the Western Canadian Sedimentary Basin (WCSB). For Phase I, development includes 15 sections with the potential for 84 targets.  Phase II transitions to field size development prospects in the range of 1.5 MMBbls of oil recoverable with potential IP's of 1,600 BOPD. The Company's exploitation development strategy centers around existing well re-completions, which confirms reservoir characteristics and lowers offset drilling risk.

Red Rock's uranium assets are in northern Saskatchewan. Since
2007, by way of acquisitions, the Company has amassed the largest land position in the region with access to 55,300 ha. This encompasses the bulk of the known radioactive occurrences and uranium deposits in the area.

Earlier in 2012, Red Rock Energy announced that they executed a Letter of Intent (LOI) with a privately held Alberta corporation (Privco). The parties shall form a Joint Venture (JV); the purpose of this JV is to complete up to six wells as identified by Red Rock and located in northeastern British Columbia.

It is the intention of the parties that Red Rock Energy will remain operator of any projects initiated. Payment terms will include reimbursing Red Rock Energy for expenses associated with prospect development, prospect acquisitions and provision of technical services. Relative to each of the prospects, Privco shall pay 100 percent of all equipping and tie-in costs to earn an 80 percent interest in that prospect.

Red Rock Energy, Inc. (RRK.V), closed Friday's trading session at $0.03, up 20.00%, on 23,000 volume. The stock's 52-week low/high is $0.02/$0.14.

Volta Resources, Inc. (VTR.TO)

Today we are reporting on Volta Resources, Inc.(VTR.TO), here at the QualityStocks Daily Newsletter.

Headquartered in Toronto, Ontario, Volta Resources, Inc. is a mineral exploration company that lists on the Toronto Stock Exchange. The Company is focusing on becoming a leader in the identification, acquisition and exploration of gold properties in West Africa. Currently, Volta Resources is fast tracking their flagship Kiaka Gold Project, located in Burkina Faso, towards a development decision. The Company has their operations offices in Accra, Ghana and in Ouagadougou, Burkina Faso.

The Company will focus on fast tracking the Kiaka Gold Project towards a development decision, aiming to have a Feasibility Study due in Q2, 2013. The recent acquisition of properties around Kiaka has provided Volta Resources with an extensive ground position along the highly prospective Markoye Fault Corridor in an important emerging gold province. The Kiaka Gold Project is on the NE trending Tenkodogo Belt. It is located on a secondary splay off the crustal N trending scale Markoye Fault.  There are 6 regional targets on highly prospective structures identified – with only the Kiaka Resource Area drilled to date. Volta has increased their land position around Kiaka along the productive Markoye Fault Corridor by 800 percent to 1,661km2.

The Company is now carrying out Whittle Enterprise Optimization to improve the economics of the project. Kiaka South mineralization will be included in the Definitive Feasibility Study. In addition, Volta Resources has their Gaoua Copper - Gold Project. This is a large land area with three contiguous concessions. It is 692.5 km2, with more than 35km of strike of mineralized corridor. Furthermore, the Company has a new discovery – Nassara. It is in the Southern Boromo Belt and is shaping up as a potentially significant new Birimian gold camp.  Additionally, Volta has their Titao Gold Project in Burkina Faso

The Kiaka Gold Project's NI-43-101 compliant resources include 117.42 million tonnes @ 1.07 g/t Au for 4,029,000 ounces in the Measured and Indicated categories and 29.96 million tonnes @ 1.00 g/t Au for 1,000,000 ounces in the Inferred category including 34.38 million tonnes @ 1.04 g/t Au for 1,145,969 ounces of gold in the Proven category and 91.70 million tonnes @ 0.93 g/t Au for 2,742,353 ounces of gold in the Probable category.

This week, Volta Resources announced that they filed a technical report on November 7, 2012 on their Kiaka South Area deposit, located 700 meters southwest of the main Kiaka Gold Deposit in Burkina Faso in West Africa, pursuant to National Instrument 43-101 - Standards of Disclosure for Mineral Projects. The Report supports the disclosure contained in Volta's news release issued on September 27, 2012, announcing the results of an updated mineral resource estimate on the Kiaka Gold Project, October 2012 by SRK Consulting UK Limited (Cardiff) (SRK). Volta Resources confirms that there are no material differences in the mineral resource estimate announced on September 27, 2012 and the results contained in the Report.

Volta Resources, Inc. (VTR.TO), closed Friday's trading session at $0.60, up 1.69%, on 236,267 volume. The stock's 52-week low/high is $0.45/$1.71.

Ascent Solar Technologies, Inc. (ASTI)

Stocks That Move reported recently on Ascent Solar Technologies, Inc.(ASTI), Street Insider, TradingMarkets, SmarTrend Newsletters, Wall Street Resources, OTCPicks, TheStockWizards.net, Investor Ideas, PennyTrader Publisher did earlier, and we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Listed on the NASDAQ Global Market, Ascent Solar Technologies, Inc. is a developer of thin-film photovoltaic modules using flexible substrate materials. The Company's modules can be directly integrated into standard building materials, commercial transportation, automotive solutions, space applications, consumer electronics for portable power and durable off-grid solutions. The Company established in 2005 to commercialize leading-edge CIGS photovoltaic technology on flexible, plastic substrate. Ascent Solar's Research and Development facility is in Littleton, Colorado. Their 30 MW nameplate production facility is in Thornton, Colorado.

The Company's innovative monolithic integration process enables the highest level of efficiency, durability and weight savings representing the potential to transform the way solar power can be used in everyday life. Ascent's technology seamlessly integrates into an unlimited range of product applications. Their modules were named one of TIME Magazine's 50 best inventions for 2011.  

Ascent Solar WaveSol™ Light provides a new way to integrate lightweight, flexible solar modules into building materials to achieve cost-effective, high-performance solar power. WaveSol™ Light modules deliver the highest power density available on thin-film plastic substrates. WaveSol™ Light modules laminate onto roofing, shading and building surfaces to decrease energy costs and provide a clean, renewable source of energy. The Company's WaveSol™ Mobile, flexible, thin-film modules for EIPV are specifically produced for integrating solar power into electronic devices and consumer products.

The Company also offers their EnerPlex Solar Charger. This solar charger utilizes their industry leading thin-film CIGS solar modules and advanced lithium-ion battery technology. EnerPlex cases are some of the thinnest and lightest battery cases available. EnerPlex for the iPhone 4, weighing less than 74 grams and with a depth of only 14mm, maintains the slim, sleek and industrial lines of the iPhone 4 & 4S.

This week, Ascent Solar Technologies announced that they were selected for an Air Force Small Business Innovative Research (SBIR) Phase 2 award to demonstrate a next-generation photovoltaic product that builds upon the Company's award-winning flexible monolithically integrated copper-indium-gallium-diselenide (CIGS) technology. The expectation is that the Air Force SBIR Phase 2 program will run 24 months with a program value of up to $750,000. This is subject to contract finalization.

Ascent Solar Technologies, Inc. (ASTI), closed Friday's trading session at $0.85, down 7.54%, on 380,734 volume with 240 trades. The average volume for the last 60 days is 794,502 and the stock's 52-week low/high is $0.3622/$2.31.


The QualityStocks
Company Corner


International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.21, off by 8.70%, on 137,500 volume with 37 trades. The stock’s average daily volume over the past 60 days is 109,024, and its 52-week low/high is $0.21/$0.69.

International Stem Cell Corp. reported Q3 2012 financial results today, with revenue for the period up year-over-year 41.7% to $1.19M led by robust sales from Lifeline Skin Care (up 46%) and Lifeline Cell Technology (up 37%), which accounted for 44% and 56% of total revenue, respectively. Cash and cash equivalents were also up 77.6% for the period, boosted by $7.03M in financing. For more details, click the following link: International Stem Cell Corp. (ISCO) Reports Greater Revenues, Lower Expenses, Stronger Cash Position.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.

A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.

In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corp Announces Third Quarter 2012 Financial Results

International Stem Cell Corporation to Host Third Quarter 2012 Financial Results Conference Call at 11:00 a.m. ET on Friday, November 9, 2012

International Stem Cell Corp's Lifeline Cell Technology Products to Be Added to Fisher Scientific's Catalogs

TNI BioTech, Inc. (TNIB)

The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $7.48, up 5.35%, on 89,203 volume with 91 trades. The stock’s average daily volume over the past 60 days is 43,792, and its 52-week low/high is $0.72/$10.01.

TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.

The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.

Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.

The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer

TNI BioTech, Inc. Company Blog

TNI BioTech, Inc. News:

TNI BioTech Inc., and Hubei Qianjiang Pharmaceuticals Co., Ltd., Announce Venture Partnership for the Development of New Drug for Cancer Therapies

Dr. Henry "Skip" Lenz, Pharm.D, Joins TNI BioTech, Inc., as Quality Control Officer

TNI BioTech Signs Agreement With Government of Malawi to Open an Oncology & Infectious Disease Clinic at Queen Elizabeth Central Hospital

Cardium Therapeutics, Inc. (CXM)

The QualityStocks Daily Newsletter would like to spotlight Cardium Therapeutics, Inc. (CXM). Today, Cardium Therapeutics, Inc. closed trading at $0.198, even with yesterday's close, on 358,069 volume with 135 trades. The stock’s average daily volume over the past 60 days is 206,826, and its 52-week low/high is $0.1771/$0.47.

Cardium Therapeutics, Inc. (CXM) is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.

The company's lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. In addition to plans to advance the product's commercialization in the U.S. and internationally via strategic partnerships, the company plans to develop new product extensions for additional wound healing applications and is working towards securing approval for marketing and sale in South Korea and through the CE Mark application process in the European Union.

Generx®, Cardium's lead clinical development product candidate, is a DNA-based angiogenic biologic designed to treat patients with myocardial ischemia due to coronary artery disease. Cardium recently initiated its Generx Phase 3 / registration study in Russia. Consistent with its capital-efficient business model, Cardium is also actively evaluating new technologies and business opportunities. The company utilizes its team's skills in late-stage product development to bridge the critical gap between promising new technologies and product opportunities that are ready for commercialization.

Cardium is dedicated to building on its core products and product candidates to continually create new opportunities for greater success. Leveraging the advantages of its capital-efficient, asset-based business strategy, the company provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value. Disclaimer

Cardium Therapeutics, Inc. Company Blog

Cardium Therapeutics, Inc. News:

European Union's First Gene Therapy Approval Represents Major Advancement For Industry

FDA Considering Faster Approval Process for Developers of Drugs for Deadly or Debilitating Diseases

Cardium Announces the Acquisition of To Go Brands

Skinny Nutritional Corp. (SKNY)

The QualityStocks Daily Newsletter would like to spotlight Skinny Nutritional Corp. (SKNY). Today, Skinny Nutritional Corp. closed trading at $0.0018, off by 14.29%, on 509,200 volume with 10 trades. The stock’s average daily volume over the past 60 days is 1,248,692, and its 52-week low/high is $0.0015/$0.0305.

Skinny Nutritional Corp. (SKNY) has established their Skinny Water® brand as a clear alternative to other products in the enhanced water space, with the only true zero calorie, sugar, carb, sodium, and preservative-containing beverage available. Skinny Water's proprietary formulation of essential antioxidant agents, electrolytes, and the critical vitamins our bodies need in order to achieve optimal function, uses 100% natural flavors, no preservatives, no artificial colors, and only the best purified water.

The company has constructed a network of approximately 50 domestic distributors (with three more internationally), placing product on shelves approximately 15k stores across the United States. Derived from the natural flavors contained in fruits, Skinny Water represents a fortified, extremely low-impact, great-tasting array of beverages that provide a concentrated punch of the nutrients essential for a healthier lifestyle.

The company's strong emphasis on health, fitness, and community has served marketing initiatives very well. The new age beverage segment has seen increasing momentum in recent years, with just about every beverage company getting into the game, but none of them has the kind of no-nonsense product composition behind Skinny Water, something that appeals directly to the majority of the core consumer market.

Skinny Nutritional continues to build value around the Skinny Water brand, and today has numerous trademarks in the healthy beverage and snack food categories. As consumers migrate away from sugar based beverages and empty calories, Skinny Water is ideally positioned to benefit from positive market trends as management focuses on delivering exceptional value to shareholders. Disclaimer

Skinny Nutritional Corp. Blog

Skinny Nutritional Corp. News:

Skinny Nutritional Corp. Provides Update on Discussions With Trim Capital

Skinny Nutritional Corp. to Change the Way You Think About Your Water With the Introduction of Skinny Water pH+

A&P's 275 Stores Continue Skinny Water's Mid-Atlantic Penetration

International Stem Cell Corp. (ISCO) Reports Greater Revenues, Lower Expenses, Stronger Cash Position

Today before the opening bell, International Stem Cell Corp., a California-based biotechnology company focused on therapeutic and research products, announced its financial results for the three months ended September 30, 2012.

Revenues for the three-month period were $1.19 million, up significantly from the $0.84 million reported for the same period in 2011. Sales for Lifeline Skin Care (LSC) and Lifeline Cell Technology (LCT) increased by 46% and 37%, respectively. According to the press release, LSC and LCT accounted for 44% and 56% of total revenue in the three months ended September 30, 2012, compared to 43% and 57%, respectively, for the same period a year earlier.

Research and development (R&D) expenses totaled $0.90 million for the three months ended September 30, 2012, down from $1.13 million for the same period in 2011. The decrease was primarily attributed to lower stock-based compensation expense, lower personnel-related spending, and lower consulting expenses, partially offset by higher stem cell line research and testing expenses and higher laboratory expenses associated with the Parkinson’s disease program.

The company continues to invest in its sales and marketing infrastructure, spending $0.48 million in the third quarter. Higher than last year, marketing expenses were increased to further promote and build awareness of the Lifeline Skin Care brand and branded products. Notably, general and administrative expenses were down 26% compared to Q3 2011, as a result of higher operational efficiency.

Cash and cash equivalents totaled $2.38 million at September 30, 2012 compared to $1.34 million as of December 31, 2011, due primarily to two financing transactions totaling approximately $7.03 million completed in the first three months of 2012.

“We have made excellent progress in our therapeutic development programs, being able to start our non-human primate study in our Parkinson’s disease program earlier than anticipated, and we remain on track to publish the results in the first half of next year,” stated Dr. Andrey Semechkin, ISCO’s CEO and Co-Chairman. “In addition, our results for the third quarter reflect good progress by LSC and LCT both in terms of growing sales and implementing their strategies. Particularly pleasing is LSC’s continued revenue growth as they aim to diversify their sales channels, and LCT’s strong quarter on quarter performance. General and administrative expenses continued to decrease reflecting our increased focus on cost containment. Looking ahead to next year, we anticipate our R&D expenses to increase further as we expand our pharmacology and safety studies and our Parkinson’s program moves closer to IND filing in early 2014.”

Q3 2012 Highlights:

• The company was granted an important patent for the liver disease program. The patent represents a new method of creating pure populations of definitive endoderm, precursor cells to liver and pancreas cells, from human pluripotent stem cells in an efficient, cost effective and scalable manner.
• Commenced rodent studies to measure the efficacy of candidate neuronal cells for the treatment of Parkinson’s disease.
• Announced the addition of two new regenerative medicine experts to our list of scientific advisors. Dr. Evan Snyder, the director of Sanford-Burnham’s stem cell program and research center, and one of the pioneers of using stem cells to treat Parkinson’s disease (PD), and Dr. Rosario Sánchez-Pernaute, a Harvard trained scientist, who has shown how parthenogenetic stem cells can be used in treating the symptoms of PD.
• Lifeline Cell Technology began selling its primary human cell and optimized media products through Fisher Scientific’s online catalog as an Encompass Preferred Supplier. Fisher Scientific is the world’s largest supplier to the life science industry with sales of approximately $12 billion, $424 million of which came from e-catalog sales in 2011.
• Lifeline Skin Care signed an agreement with Sinopharm Group to distribute LSC’s anti-aging skin care products in China and made the first shipment. Sales of cosmetic products in mainland China is estimated to be approximately $8 billion and growing by over 10% per annum.

In less than two hours, International Stem Cell Corp. will be hosting a conference call. Those wishing to participate should dial 877-317-6776 shortly before 11:00am ET. International callers should dial 412-317-6776. Once connected, participants should provide the conference ID 10020806. To access the call via webcast, visithttp://webcast.mzvaluemonitor.com/Home/Login/630.

A replay of the conference call will be available through end date: November 26, 2012 at 9:00 am ET. If anyone is unable to join at 11:00am ET this morning, they should dial 877-344-7529 and enter the conference ID 10020806 when they have time. International callers should dial 412-317-0088, and then use the same conference ID number.

For more information, visit www.internationalstemcell.com

Skinny Nutritional Corp. (SKNY) Offers More Than Just Flavor Without Guilt

Skinny Nutritional is a Pennsylvania based maker of enhanced functional beverages, now distributed all over the country under the brand name Skinny Water. Skinny Water is unique in the fact that it contains 100% natural flavorings, with no sugar, no carbs, no calories, and no sodium. What it does have is a unique formulation of vitamins, electrolytes, and antioxidants, making it one of the healthiest drinks available anywhere, in a different league than standard enhanced waters that are often loaded with artificial sweeteners and chemicals. As such, it has rapidly become popular with people looking for something refreshing and delicious, but not fattening. Unlike sugared or diet sodas, people can enjoy as much as they want without feeling guilty about their health or weight.

But Skinny Water is far more than just flavor without the guilt. Skinny Water represents a bold new direction for the beverage industry, a direction that could cut significantly into the vast global market for non-alcoholic beverages. Moreover, it’s a direction that is already being actively encouraged by local, state, and federal agencies, a level of support that is destined to increase. The reason, of course, is that traditional soda drinks, including diet sodas, are being recognized as contributors to the ever growing obesity problem in America. Even diet sodas are now considered suspect, with researchers suggesting their artificial sweeteners may react chemically with the body to drive additional consumption.

The numbers have been mounting so fast for obesity, including childhood obesity, that individuals and all levels of government are desperately seeking solutions. With nearly 70% of adults listed as overweight or obese, what used to be a personal problem is now viewed as an epidemic. Although there are many contributing factors, the bottom line is that people are taking in more calories and fat while exercising less. As the computer age has grown, so has the American waistline. Cheap mass-produced high-calorie fillers and flavorings, such as corn syrup, staples in processed food products, are becoming a big part of our diet as more people seek ready-to-eat foods. And the amount eaten at every sitting has also gone up.

Consumers are recognizing the risk for themselves and want alternatives. Skinny Water stands in stark contrast to common processed foods and beverages, which is why it has become so popular in such a short time. The global beverage market is huge, and Skinny Nutritional is starting to cut into it.

For additional information, visit www.SkinnyWater.com

Ocean Power Technologies, Inc. (OPTT) Appoints Dr. Mike Mekhiche New Head of Engineering

Ocean Power Technologies (OPT), a leading wave energy technology company, announced that Dr. Mike M. Mekhiche has been appointed Vice President, Engineering. Dr. Mekhiche, who holds Doctorate and Masters degrees with honors in Electrical Engineering from the Grenoble Institute of Technology, joins Ocean Power Technologies from BAE systems, where he most recently held the position of Director of Programs.

Ocean Power Technologies has stated that Dr. Mekhiche will be responsible for overseeing the company’s engineering and advanced technology development, and will be reporting to Charles F Dunleavy, Chief Executive Officer of OPT. Dr. Mekhiche primary responsibilities will include technology delivery, furthering enhancements and development of OPT’s wave energy technology portfolio, and the development of the next generation of PowerBuoy® systems.

“We are very pleased to have Mike Mekhiche join OPT as Vice President, Engineering. He brings a wealth of demonstrated technical innovation, leadership of engineering teams and experience in strategic management of the technology development process,” said Charles F. Dunleavy, Chief Executive Officer of OPT. “Mike has a proven track record of success in engineering management at technology-based companies and sensitivity to the needs of an international customer base. He has shown the ability to bridge between the process of continuous innovation and its implementation in successful commercial strategies. This background is important to OPT’s growth as we progress in the commercialization of our core PowerBuoy technology, and we welcome him to the senior management team.”

With over twenty years of experience in new product development and commercialization of electro-mechanical and control systems for industrial equipment, land vehicles and sea vessels, Dr. Mekhiche also has a great deal of experience in the US Department of Defense, automotive industry, and machinery markets, as well as serving customers in the renewable energy sector. Mekhiche has also worked extensively for both small and large companies, and has led multi-discipline engineering teams servicing customers across North America, Asia and Japan, and Europe.

Dr. Mekhiche worked as the Director of Programs for seven years at BAE Systems, a large global defense and aerospace contractor. As the Director of Programs, Mekhiche oversaw the design, development, production, and systems integration of an advanced power management and hybrid propulsion product line for use in various applications, such as naval vessels, heavy duty commercial vehicles, and military combat and tactical platforms. Before being appointed Director of Programs, Dr. Mekhiche held the position of Chief Engineer and was responsible for directing development, systems integration, and deployment of advanced systems for both land and sea applications in both the military and commercial sectors.

Formerly, before his work at BAE Systems, Dr. Mekhiche worked as the Technical Director for New Technology Development at DRS Technologies, Inc., a manufacturer of advanced products for the defense industry. During his tenure at DRS, Mekhiche managed a large engineering development program centered around technology integration for electrically-propelled ships for use by the US Navy. Prior to DRS, he worked for SATCON Technology Corp., a clean energy technology company which provided utility-grade power conversion solutions for the renewable energy market. While working at SATCON, Dr. Mekhiche was General Manager in the Power Systems division, where he led the commercialization of the SATCON’s power management and conversion products.

FuelCell Energy, Inc. (FCEL) Secures 121.8 MW Order from South Korean Partner POSCO Energy Valued at $181M

FuelCell Energy, the Danbury, Connecticut-based designer, manufacturer, and operator/servicer of ultra-clean, highly efficient, and extremely reliable stationary fuel cell power plants for a variety of distributed generation roles, reported an order today valued at roughly $181M (multi-year contract) for 121.8MW of fuel cell kits and services via POSCO Energy, FCEL’s partner in South Korea.

This comes as a result of POSCO Energy’s recent engagement under contract to execute on a joint-owned and developed 58.8MW fuel cell park project designed to meet targets set by South Korea’s ambitious 2012 RPS (renewable portfolio standard). The hardware will be manufactured at FCEL’s production facility over in Torrington, CT, from which the company’s over 50 global installations and 1B kWh of generated power (300MW of generation capacity installed or in backlog) have come in the form of their revolutionary Direct FuelCell® (DFC) power plants.

Senior VP at POSCO, Jung-Gon Kim, noted how this massive order would help meet growing demand in South Korea and other Asian markets, with the bulk of the hardware going to offset RPS targets via the 58.8MW fuel cell park and other renewable power projects. Mr. Kim emphasized that construction would start before the year is out and with the first delivery of equipment slated for May 2013 (to ensure a steady supply stream of kits as deliveries under the existing 70MW order end in the preceding April), the widespread demand for virtually emission free, super-efficient fuel cell power generation in South Korea will begin to see traction as earlier as next year.

This kind of exposure is a huge boon for FCEL and the 1.4MW fuel cell kits they have developed are highly prized for their modularity and interchangeability. The product can be stacked up all the way to megawatt class installations or simply used for sub-megawatt generation projects, a great advantage for fuel cell-based implementations, as they can be relatively small at first and then simply be upgraded as more units are added to the generation matrix. Power from this fuel cell park will be sold directly into the grid and the facility will even harness the ambient, otherwise wasted heat energy for sale to the district heating system.

Exciting times for fuel cells in Asia as government agencies move to develop green-industry that will support economic robustness in rudimentary systems like power generation. Even more exciting times for FCEL shareholders who stand to profit handsomely as the company’s already established fuel cell power plants capture the zeitgeist perfectly. Fuel cell energy from DFC plants offers clear efficiency advantages over other forms of distributed generation, with up to 90% overall efficiency in combined heat and power applications.

President and CEO of FCEL, Chip Bottone, quite pleased with what is the largest order ever received by the company and industry, hailed the deal as a real milestone. This order almost triples the company’s backlog and has tipped off a planned increase in production capacity for 2013, driven by strong market acceptance in South Korea, as well as the larger Asian market taken as a whole. Bottone characterized the power generation and job creation model as something which should be emulated globally, and with this kind of revolutionary technology at our fingertips, it is not hard to see that the future is very bright indeed for FCEL.

To learn more about FuelCell Energy, visit www.FuelCellEnergy.com


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters





PennyTrader Publisher


EpicVIP Group

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors

The QualityStocks By The Numbers Report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251